Triage Clinical Trial - Risk Stratification in Acute Care: The Meaning of

Status Completed

Clinical Trial Summary

Will clinical outcome for patients be improved if triage in Acute wards and Emergency rooms is supplemented with a prognostic biomarker?

Clinical Trial Description

In a health care system where the general population is growing, more patients are living with chronic conditions and the hospitals are reducing beds and length of stay, it is crucial to perform safe and fast risk stratification of patients presenting in the Emergency departments. Risk stratification is currently performed with a combination of measurement of the vital signs and assessment of the primary complaint. The aim of the current study is to assess whether the supplement of biomarkers can improve the risk stratification in regard to mortality, readmissions and improve overall patient flow in the Emergency departments. Soluble urokinase plasminogen activating receptor (suPAR) is the soluble form of urokinase-type plasminogen activator receptor (uPAR). uPAR is present on various immunological active cells, as well as endothelia and smooth muscle cells. It is believed that suPAR mirrors the inflammatory response in patients. Previous studies have shown a strong association with mortality and severity of disease in a broad variety of conditions (infection, hepatic-, renal-, cardiac- and lung disease) as well as a possible marker of disease development in the general population. These abilities indicate that suPAR although unspecific would be ideal to identify patients at high- and at low-risk. The aim is to target interventions and limited clinical focus where it is most beneficial. In unselected patients suPAR is one of the strongest prognostic biomarker available to date. It is not known whether information on prognosis in the Emergency department can be used to prevent death, serious complications or reduce admissions and readmissions. The purpose of the current study is to examine if introduction of the biomarker suPAR and education of doctors in the meaning of suPAR levels and association to disease, can reduce mortality, admissions and readmission in patients referred to the emergency rooms. ;

Study Design

Related Conditions & MeSH terms

Risk Stratification With Biomarker
Triage

Clinical Trial Details

NCT number	NCT02643459
Study type	Interventional
Source	Herlev Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 2016
Completion date	April 6, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04301206` - Videos and Simple Text to Empower Parents to Handle Their Sick Children	N/A
Completed	`NCT02559531` - Reliability of the Swiss Emergency Triage Scale (SETS®) Used by Emergency Medical Service (EMS) Providers	N/A
Completed	`NCT01219868` - Physician-nurse Team to Reduce Emergency Department (ED) Overcrowding	N/A
Recruiting	`NCT06034184` - Enhancing Mass Casualty Triage Through Virtual Reality Simulation	N/A
Completed	`NCT04055298` - Is Self-triage by Patients Using a Symptom-checker Safe?	N/A
Completed	`NCT02980159` - Impact of a Triage Liaison Physician	N/A
Completed	`NCT03401411` - ICU Triage Practices in a Cancer Hospital	N/A
Recruiting	`NCT03357835` - Trauma Triage Decision With Software (TraumaDS)	N/A
Completed	`NCT04474236` - Lung Ultrasound for COVID-19 Initial Triage and Monitoring
Enrolling by invitation	`NCT06332586` - The Learning Effect of Applying Diversified Teaching in Emergency Injury Classification -Taking the Emergency Nurse of a Regional Hospital in Yunlin County as an Example	N/A
Completed	`NCT05944406` - Enhancing Triage Accuracy: A Clinical Audit of the Manchester Triage System Implementation
Active, not recruiting	`NCT04137874` - Paramedic - Norwegian Acute Stroke Prehospital Project	N/A
Completed	`NCT02090452` - Mobile Transmission of Prehospital Vital Signs to the Emergency Department	N/A
Completed	`NCT05473988` - Optimization of Treatment Priority of the Manchester Triage System
Recruiting	`NCT04923308` - The Effect of Chiropractor-informed Triage on Low Back Pain Patient Outcomes and Trajectories
Completed	`NCT01434433` - Alere Triage fs B-type Natriuretic Peptide (BNP) Method Comparison Evaluation
Completed	`NCT05388292` - Decision Support System on Emergency Triage	N/A
Recruiting	`NCT03720106` - The Way to Goal-oriented Therapy Planning in Neurorehabilitation	N/A
Completed	`NCT03793972` - Triaging and Referring in Adjacent General and Emergency Departments	N/A
Enrolling by invitation	`NCT04862936` - The Prediction Model of Elderly Patients in Taiwan Triage and Acuity Scale

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage — suPAR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms